Pt Prodia Widyahusada Tbk · IDX:PRDA
Pt Prodia Widyahusada Tbk — FY2018 Earnings Presentation
27 slides from Pt Prodia Widyahusada Tbk's earnings presentation, Apr 2, 2019
Slide 1: Full Year 2018 Results Update
Full Year 2018 Results Update 02 April 2019
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by PT Prodia Widyahusada (the "Company") solely for use in connection with the analyst presentation relating to the Company. The information contained in this presentation is strictly confidential and is provided to you solely for your reference. By vie
Slide 3: Market & Business Highlights
Market & Business Highlights 3
Slide 4: Largest Network & Market Share in Independent Clinical Lab Industry
Largest Network & Market Share in Independent Clinical Lab Industry Market Share by Revenue Independent Clinical Labs (2016 & 2017) 38.5% 38.7% 29.2% 2016 29.0% 2017 32.3% 32.3% Source: IQVIA Analysis (2018) 4
Slide 5: Potential Growth for Esoteric & Genetic Testing
Potential Growth for Esoteric & Genetic Testing Esoteric Testing Market Global Statistics Regional Outlook > USD 19 Billion 9.4% Germany China Market US Industry Market CAGR CAGR Share (2017) (2018-2024) (2018-2024) CAGR 2018-2024 Industry Size (2017) 35% 8.5% 12.5% The Esoteric Testing Industry is
Slide 6: Potential Growth for Advanced & Genetic Testing
Potential Growth for Advanced & Genetic Testing Genetic Testing Market Global Statistics Landscape By Application Cancer Diagnosis Cardiovascular Revenue Share Disease Diagnosis (2017) CAGR (‘18-’24) USD 5.6 Billion 12.8% USD 10.6 Billion >11.6% By Testing Type Diagnostic Prenatal and Testing Revenu
Slide 7: Comprehensive Service Offering
Comprehensive Service Offering Targets Multiple Customer Segments Routine Testing Non-Laboratory Testing Specialty Clinics Esoteric Testing Referral Lab Services Doctor Consultation Predictive, Preventive, General Medical Preventive Treatment Personalized Package Check-Up Services Testing Walk-In Cu
Slide 8: Prodia Laboratories
Prodia Laboratories Indonesian Pioneer in Clinical Laboratory Testing Received SMK3 accreditation and OHSAS 2015, along with the Award as "Diagnostic Services Company of the Established professional Year 2015" from Frost & Sullivan management team Opened the first green building used for labor
Slide 9: 2018 Highlighted Stories
2018 Highlighted Stories New Outlets, Esoteric & Genomic Tests, Human Capital Developments & Digital Services Prodia Prodia Nationwide Genomics Lab Information Corporate University Network Launched: Security • Established ProU (Prodia • Opened 6 (six) • Anatomical Corporate University) new outlets P
Slide 10: 2018 Expansion, Innovation & Collaboration Milestones
2018 Expansion, Innovation & Collaboration Milestones Officially operating Launched in all 34 Provinces in ProHealthy Gut Indonesia, Prodia Extension of Opens New MoU in Research Launched Branch in and Education EGFR ctDNA Launched centralized Bengkulu with Faculty of Mutation for call center, Konta
Slide 11: Scalable Hub and Spoke Model
Scalable Hub and Spoke Model Significant Economies of Scale Achieved Prodia Clinical Labs, Centralized information Hospitals and Other Prodia Referral with integrated IT “Hub and spoke” model Clinics may refer tests to Lab Services platform that connects offers scalable platform PRLS (PRLS) each lab
Slide 12: Most Recognized Clinical Lab Brand in Indonesia
Most Recognized Clinical Lab Brand in Indonesia Wow Brand Top Corporate Solo Jogja Best Outstanding Award Brand Image Award Best Brand Best Brand E Mark Corporate 2015, Award (IMAC) Index Index 2016 & Innovator, 2017-2018 2009 - 2018 2012 - 2018 2015 - 2018 2015 - 2018 2018 2018 2012 - 2018 Indonesi
Slide 13: Senior Leadership and Management Team
Senior Leadership and Management Team Experienced, Professional Management Team with a Track Record in Delivering Superior Growth and Innovation Years of Years of Years of Years of Years of 46 Experience 46 Experience 36 Experience 30 Experience 32 Experience Andi Gunawan Endang Scott Andrew Lukas S
Slide 14: Shareholder Composition
Shareholder Composition PT Prodia Utama Bio Majesty Pte. Ltd. Public 57% 18% 25% Contract Research, therapy Distributor for Research and banking of healthcare Organization stem cell products PT Prodia Widyahusada Tbk Occupational In Vitro Health Diagnostics Nationwide Outlet Network across Indonesia
Slide 15: Growth Strategy
Growth Strategy 15
Slide 16: Growth Strategy
Growth Strategy A Near-term B Long-term Expand our presence and grow Focus on the development of next- our network of outlets in both generation diagnostic existing and new markets in technologies for precision medicine Indonesia Upgrade existing clinical laboratories to provide wider range of tests
Slide 17: Near Term Growth Plan
Near Term Growth Plan Prodia’s Network Expansion Plan 2016 - 2021 1 2 3 4 Expand Network Upgrade Clinical Enhance Operating Focus on of Outlets Labs Efficiency Quality 4 regional referral labs Upgrade up to 39 clinical labs to PHC Clinics Up to 33 additional clinical labs over next five years 24 Cli
Slide 18: FY2016-FY2018 Existing Outlets and FY2019 Targets
Business Updates FY2016-FY2018 Existing Outlets and FY2019 Targets 129 118 9 2 FY2016 259 Outlets Clinical Labs POC Outlets Hospital Labs Specialty Clinic 136 130 11 5 FY2017 283 Outlets Clinical Labs POC Outlets Hospital Labs Specialty Clinic 143 128 14 7 FY2018 292 Outlets Clinical Labs POC Outlet
Slide 19: Leader in Next Generation Technology
Leader in Next Generation Technology Research Evaluation Laboratory Laboratory Mass Spectrometry & Molecular Separation Next Generation Diagnostic Science Laboratory Laboratory Laboratory Anatomical Advance Pathology Immunology Laboratory Laboratory Personalized Treatment The Concept of Precision Me
Slide 20: FY2018 Business & Financial Updates
FY2018 Business & Financial Updates 20
Slide 21: New Clinical Lab & Specialty Clinic Outlets FY2018
Business Updates New Clinical Lab & Specialty Clinic Outlets FY2018 143 Clinical Labs Clinical Lab, 292 outlets Prodia Children Health Centre Prodia Women’s Health Centre 7 3 4 Bengkulu 34 provinces Medan, North Sumatera Medan, North Sumatera 123 cities May 2018 Dec 2018 FY2018 Feb 2018 Jun 2018 Jul
Slide 22: FY2018 Revenue (Audited)
Business Updates FY2018 Revenue (Audited) Revenue (in IDR Billion) FY14-FY17 CAGR +10.0% Growth +9.1% 1,599.8 1,466.0 1,359.0 1,197.7 Revenue continues to 1,101.0 rise along with improvements in volume, growth in external referrals, as well as increase in revenue & test per visit 2014 2015 2016 2017
Slide 23: Technology to increase Customer Satisfaction
Business Updates Technology to increase Customer Satisfaction • Launched e-Prodia, an Online Order & Result Platform, further expanding our distribution channel and providing easier registration, payment system, and access to results for our customers. • Customers can choose type of testing & the ou
Slide 24: Technology to increase Customer Satisfaction
Business Updates Technology to increase Customer Satisfaction Online Order via Prodia Mobile Online Results via Prodia Mobile 24
Slide 25: FY2018 Gross Profit & Net Income
Financial Updates FY2018 Gross Profit & Net Income Gross Profit (in IDR Billion) Net Income (in IDR Billion) Growth +7.6% Growth +10.5% Growth +71.1% Growth +16.3% 942.8 175.5 150.8 853.5 88.1 793.4 11.0% 10.3% 58.4% 58.2% 58.9% 6.5% 2016 2017 2018 2016 2017 2018 Net Income Margin Gross Profit Margi
Slide 26: FY2018 COGS & OPEX
Financial Updates FY2018 COGS & OPEX COGS (in IDR Billion) OPEX (in IDR Billion) CAGR 2014-2017+10.5% g+7.3% CAGR 2014-2017+8.3% g +8.1% 700 612 657 80.0% 565 1,000 150.0% 600 511 114 770 101 713 500 454 90 60.0% 800 676 82 560 607 46 72 41 100.0% 400 600 39 40.0% 36 300 42.7% 33 42.0% 41.6% 41.8% 4
Slide 27: Thank You
Thank You For more information : PT Prodia Widyahusada Tbk Investor.Relation@prodia.co.id Prodia Tower, Jl. Kramat Raya No. 150, Jakarta 10430, Indonesia Phone +6221.3144182 ext. 3774, 3775 http:/www.prodia.co.id